Regeneron AA Multicenter (Dupilumab)

NCT05551793 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

Emma Guttman

Collaborators

[object Object]